NTRA Q3 2024 Earnings — Natera, Inc. Revenue & Financial Results | Market Cap Arena

NTRANatera, Inc.

$29B

Q3 2024 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$440M+63.9% YoY

Gross Profit

$272M61.8% margin

Operating Income

-$39M-8.9% margin

Net Income

-$32M-7.2% margin

EPS (Diluted)

$-0.26

QoQ Revenue Growth

+6.4%

Cash Flow

Operating Cash Flow

$52M

Free Cash Flow

$35M

Stock-Based Comp.

$71M

Balance Sheet

Total Assets

$1.6B

Total Liabilities

$712M

Stockholders' Equity

$879M

Cash & Equivalents

$893M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$440M	$268M	+63.9%
Gross Profit	$272M	$121M	+124.6%
Operating Income	-$39M	-$111M	+64.6%
Net Income	-$32M	-$109M	+71.0%

Revenue Segments

Product

$436M99%

Licensing and other

$4M1%

Geographic Segments

United States

$426M97%

Europe, Middle East, India, Africa

$8M2%

Asia Pacific and Other

$4M1%

Americas, excluding U.S.

$2M0%